The reported 13% year-over-year increase in net revenue for NovaBay's eyecare and wound care business segments indicates a positive growth trajectory for the company. This growth is likely to be viewed favorably by investors, potentially leading to a positive short-term impact on the stock price. The specific mention of the revenue increase and its attribution to key business segments enhances the relevance and importance of this news for investors in NBY.